6124 SARS-CoV-2 S1 IgA

Intended Use:

The AESKULISA SARS-CoV-2 S1 IgA test is a qualitative and quantitative immunoassays for the demonstration of human IgA antibodies in serum or plasma directed against the S1 domain of the spike protein of SARS-CoV-2. The AESKULISA SARS-CoV-2 S1 IgA test assists in the detection of acute infections.

Recombinant Antigens:

Recombinant S1 domain of the spike protein of SARS-CoV-2

Native Antigens:

n.a.

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 6124
Description: SARS-CoV-2 S1 IgA
Kit Configuration: Single - A
Cut Off: 8-12 U/ml
Range: 3 - 100 U/ml
Standard: -
Antibodies: IgA